How do dermatologists use phototherapy for conditions like vitiligo or psoriasis?
Phototherapy, also known as light therapy, is a well-established, evidence-based treatment dermatologists use for various skin conditions, including vitiligo and psoriasis. The approach involves exposing the skin to specific wavelengths of ultraviolet (UV) light under controlled medical supervision. By leveraging precise dosing and timing, dermatologists aim to slow the rapid skin cell turnover seen in psoriasis or to stimulate pigment production in vitiligo patches.
How Phototherapy Works for Psoriasis
In psoriasis, the immune system triggers an overproduction of skin cells, leading to thick, scaly plaques. Phototherapy works by penetrating the skin and slowing this cell growth. The most common types used include:
- Narrowband UVB (NB-UVB): This is the most frequent form, emitting a specific wavelength (311-313 nm) that targets the hyperactive immune cells in the skin. Multiple sessions per week are typical, often showing improvement within weeks.
- Broadband UVB: An older method that uses a broader range of UVB light, less commonly used today due to higher risk of burning.
- PUVA (Psoralen + UVA): Combines a photosensitizing medication (psoralen) with UVA light. This is reserved for more resistant cases due to higher long-term risk of skin damage.
Dermatologists customize the dose based on skin type and severity, starting low and gradually increasing to reduce the risk of sunburn. Clinical studies indicate that around 70-80% of patients with plaque psoriasis see significant improvement with consistent NB-UVB therapy.
How Phototherapy Works for Vitiligo
For vitiligo, where melanocytes (pigment-producing cells) are destroyed, phototherapy aims to repigment the white patches. Dermatologists primarily use:
- Narrowband UVB (NB-UVB): This is the first-line phototherapy for generalized vitiligo. It stimulates melanocyte stem cells in hair follicles to produce pigment, which then spreads across the patch. Results often take several months, with repigmentation starting as tiny spots (perifollicular repigmentation).
- Excimer Laser (308 nm): A targeted form of UVB focused only on affected patches. This allows higher doses to the skin without exposing surrounding healthy skin. It is often used for smaller, localized patches, such as on the face or hands.
Dermatologists stress that consistency is key in vitiligo; patients typically need 2-3 sessions per week for 6 months or more to see meaningful repigmentation. Response rates vary widely, with facial areas often responding best.
What to Expect from In-Office Phototherapy
In-office phototherapy is conducted in a dermatology clinic or hospital setting using specialized light booths or handheld devices. A typical session lasts just a few minutes. Dermatologists follow strict protocols to minimize side effects, which include short-term redness, dryness, and, rarely, blistering. Long-term risks include increased skin aging and skin cancer risk, which is why treatment is carefully monitored and limited.
When Home Phototherapy May Be an Option
For motivated patients with stable, widespread disease, some dermatologists may prescribe home phototherapy units. These require thorough training on how to use the device safely and track doses. However, in-office treatment remains the standard because it allows for more precise dose adjustments and immediate oversight. Readers interested in this option should discuss it directly with their board-certified dermatologist to assess suitability and insurance coverage.
Important Considerations
Phototherapy is not suitable for everyone. Dermatologists may avoid it in patients with a history of skin cancer, photosensitive disorders, or those taking certain medications that increase sun sensitivity. It is also not a cure for either psoriasis or vitiligo; rather, it is an effective management tool that can clear or reduce symptoms. For personalized guidance on whether phototherapy is right for your specific diagnosis, schedule a consultation with a board-certified dermatologist.